Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 19, Issue 4, Pages 672-675Publisher
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2007090981
Keywords
-
Categories
Funding
- NCI NIH HHS [CA-114000, CA-40035] Funding Source: Medline
- PHS HHS [U54-126505] Funding Source: Medline
Ask authors/readers for more resources
It is now 20 years since the tumor-associated factor parathyroid hormone-related peptide was identified. Since then, there have been significant changes in the understanding of the hypercalcemic syndromes associated with malignancy and with the role of this peptide in normal physiology as well as this specialized pathologic setting. Parathyroid hormone-related peptide has become a useful diagnostic tool in the differential diagnosis of hypercalcemia, and approaches to inhibit its expression or its effects by malignant cells hold promise for treating the hypercalcemia and osteolysis associated with some cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available